Mizuho raised the firm’s price target on Cardinal Health to $104 from $95 and keeps a Neutral rating on the shares. The company’s Medical segment beat expectations as it continues to execute on its recovery plan, the analyst tells investors in a research note. The firm cites valuation for the Neutral rating.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on CAH:
- Options Volatility and Implied Earnings Moves Today, November 03, 2023
- Cardinal Health raises FY24 EPS view to $6.75-$7.00 from $6.50-$6.75
- Cardinal Health reports Q1 adjusted EPS $1.73, consensus $1.40
- Cardinal Health Reports First Quarter Fiscal 2024 Results and Raises Fiscal 2024 Outlook
- Notable companies reporting before tomorrow’s open
Questions or Comments about the article? Write to editor@tipranks.com